Biotest share

Shareholder information

Shareholder Structure

The data shown was taken in each case from the latest announcement communicated by the shareholder.

Ordinary Shares:
Release according to § 33 Abs. 1 WpHG:**
96.20%   Grifols S.A.*
0.13%   Polygon Global Partners LLP
0.07%   UBS Group AG
*: On 2 May 2022, Grifols, S.A. published in accordance with sec. 23 para. 2 sentence 1 WpÜG, that Grifols, S.A. acquired further 0.94 % of the voting rights in Biotest AG. Therefore, Grifols, S.A. holds 97.14 % of the voting right in Biotest AG.
** On 6 June 2025, Grifols Biotest Holding GmbH announced in its final announcement that a further 2.1072% of Biotest ordinary shares had been accepted. Grifols S.A. now holds a total of 99.25% of the voting rights in Biotest AG.
Preference Shares:
100.00%   Free float